SCHEMBL256685

SCHEMBL256685

CCc1ccoc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28733650 0.89 ALOX5 (0.47)
SCHEMBL19792665 0.81 ALOX5 (0.47)
SCHEMBL9768922 0.80
SCHEMBL10943898 0.77
SCHEMBL8008537 0.77
SCHEMBL1756881 0.77
SCHEMBL702163 0.77
SCHEMBL9686374 0.77
SCHEMBL11263930 0.77 ALOX5 (0.41)
SCHEMBL2554201 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025041793-A1 ORAL COMPOSITION CONTAINING ARTIFICIAL NANOFIBERS, AND METHOD FOR PRODUCING ARTIFICIAL NANOFIBERS 国立大学法人 岡山大学 2025-02-27 WO disclosed
CN-114423294-A Coffee replica made from individual components 航行食品股份有限公司 2022-04-29 CN disclosed
WO-2019149260-A1 PYRIDAZINOL COMPOUND, DERIVATIVE THEREOF, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF 青岛清原化合物有限公司 2019-08-08 WO disclosed
US-20180021467-A1 METHOD OF BLOCKING PERCEPTION OF MALODOR MONELL CHEMICAL SENSES CENTRE (US) 2018-01-25 US disclosed
EP-1921077-B1 AGENT FOR TREATING AND/OR PREVENTING SLEEP DISORDER KYOWA HAKKO KIRIN CO LTD (JP) 2017-07-26 EP disclosed
EP-2746285-B1 Process for the preparation of aurora kinase inhibitors MILLENNIUM PHARM INC (US) 2016-09-14 EP disclosed
US-20140200215-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-17 US disclosed
US-20120157403-A1 BICYCLIC AND TRICYCLIC DERIVATIVES AS THROMBIN RECEPTOR ANTAGONISTS CHACKALAMANNIL SAMUEL (US) 2012-06-21 US disclosed
US-8153664-B2 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer SCHERING CORPORATION (US) 2012-04-10 US disclosed
US-20120071517-A1 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES BAYER SAS (FR) 2012-03-22 US disclosed
EP-2196459-A1 5-MEMBERED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-16 EP disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed
US-7576117-B1 Cyclic amine CCR3 antagonist TEIJIN LIMITED (JP) 2009-08-18 US disclosed
US-20090137611-A1 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives BAYER CROPSCIENCE AG (DE) 2009-05-28 US disclosed
US-20080090830-A1 Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists SCHERING CORPORATION 2008-04-17 US disclosed
US-20070078152-A1 Piperidine derivatives AMGEN INC. 2007-04-05 US disclosed
WO-2007036733-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2007-04-05 WO disclosed
CN-1193018-A Process for preparing alky 2-methyl-3-furyl-disulfo ether BEIJING LIGHT INDUSTRY COLLEGE (CN) 1998-09-16 CN disclosed
US-5386063-A Forming a synthetic carotenoids chemical intermediates by reacting triethyl-2-phosphonopropionate with fumarylaldehyde and/or fumarylaldehyde dimethylacetal containing carbon isotope THE CATHOLIC UNIVERSITY OF AMERICA (US) 1995-01-31 US disclosed